Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide

Haematologica
Michel DelforgeThierry Facon

Abstract

We compared the health-related quality-of-life of patients with newly diagnosed multiple myeloma aged over 65 years or transplant-ineligible in the pivotal, phase III FIRST trial. Patients received: i) continuous lenalidomide and low-dose dexamethasone until disease progression; ii) fixed cycles of lenalidomide and low-dose dexamethasone for 18 months; or iii) fixed cycles of melphalan, prednisone, thalidomide for 18 months. Data were collected using the validated questionnaires (QLQ-MY20, QLQ-C30, and EQ-5D). The analysis focused on the EQ-5D utility value and six domains pre-selected for their perceived clinical relevance. Lenalidomide and low-dose dexamethasone, and melphalan, prednisone, thalidomide improved patients' health-related quality-of-life from baseline over the duration of the study across all pre-selected domains of the QLQ-C30 and EQ-5D. In the QLQ-MY20, lenalidomide and low-dose dexamethasone demonstrated a significantly greater reduction in the Disease Symptoms domain compared with melphalan, prednisone, thalidomide at Month 3, and significantly lower scores for QLQ-MY20 Side Effects of Treatment at all post-baseline assessments except Month 18. Linear mixed-model repeated-measures analyses confirmed the resul...Continue Reading

Citations

Aug 28, 2016·Journal of Geriatric Oncology·Nicolas Kint, Michel Delforge
Aug 17, 2016·European Journal of Haematology·Christina RamsenthalerIrene J Higginson
Oct 22, 2016·Blood Cancer Journal·B LipeJ Mikhael
Jun 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cyrille HulinThierry Facon
Mar 23, 2017·European Journal of Haematology·Lene Kongsgaard NielsenNiels Abildgaard
Jul 25, 2017·Journal of Managed Care & Specialty Pharmacy·Ying ChenXianglin L Du
May 4, 2016·The American Journal of Hospice & Palliative Care·Fiona KielyTony O'Brien
Jan 19, 2019·British Journal of Haematology·Lene Kongsgaard NielsenTobias Wirenfeld Klausen
Apr 2, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph MikhaelTom Martin
May 16, 2019·Expert Review of Hematology·Samantha SeitzlerRachid Baz
Jun 30, 2019·Expert Review of Hematology·Massimo MartinoMassimo Gentile
Sep 13, 2019·Applied Health Economics and Health Policy·Jenny ClelandJulie Ratcliffe
Sep 26, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Katja WeiselHartmut Goldschmidt
Mar 2, 2019·Current Hematologic Malignancy Reports·Saurabh ZanwarPrashant Kapoor
Aug 8, 2015·Expert Opinion on Pharmacotherapy·Annemiek Broijl, Pieter Sonneveld
May 10, 2018·British Journal of Haematology·Elizabeth K O'DonnellNoopur S Raje
Oct 13, 2020·Hematology Reports·Daniele DerudasClaudio Cerchione
Sep 22, 2020·Panminerva Medica·Daniele DerudasClaudio Cerchione
Aug 9, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Dominik GolickiMaciej Niewada
Dec 29, 2020·Clinical Lymphoma, Myeloma & Leukemia·Joshua RichterStuart L Goldberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.